526
Participants
Start Date
March 5, 2021
Primary Completion Date
January 27, 2022
Study Completion Date
March 1, 2022
Insulin degludec
Participants will receive subcutaneous (s.c.) injections of insulin degludec once daily for 26 weeks
Insulin Icodec
Participants will receive subcutaneous (s.c.) injections of insulin icodec once weekly for 26 weeks
MMA-MHAT Sofia, Clinic of Endocrinology and Metab. Diseases, Sofia
Hemant Makan, Johannesburg
Chris Hani Baragwanath Hospital, Johannesburg
Centre for Diabetes, Johannesburg
'Medical center Medi city 21' OOD, Kyustendil
OCIPSOMCEMD ENDO MED-CONSULT - Dr. Nikolay Botushanov, Plovdiv
Dr A Amod, Durban
Greenacres Hospital, Port Elizabeth
ASOMCEM - IP - Dr. Antoanela Slavcheva, Rousse
Medi-Clinic Bloemfontein, Bloemfontein
Albany Medical College - Endo, Albany
Seoul National University Bundang Hospital, Gyeonggi-do
Endo And Metab Cons, Rockville
Wendisch/Dahl Hamburg, Hamburg
PharmQuest Life Sciences LLC, Greensboro
Accellacare, Wilmington
Endo Res Solutions Inc, Roswell
South Broward Research LLC, Miramar
Renstar Medical Research, Ocala
InnoDiab Forschung GmbH, Essen
Ternopil Central District Hospital, Ternopil
Velocity Clin. Res Valparaiso, Valparaiso
Institut für Diabetesforschung GmbH Münster - Dr. med. Rose, Münster
Clinic of Medical Academy, Dnipro, Dnipro
Wenzl-Bauer, Rehlingen-Siersb., Rehlingen-Siersburg
New Orleans Center for Clinical Research, New Orleans
Marienhospital Stuttgart - Innere Medizin 1, Stuttgart
Erlinger, Stuttgart
Velocity Clinical Res-Dallas, Dallas
Diabetes and Thyroid Ctr of FW, Fort Worth
Hillcrest Family Health Center, Waco
PlanIt Research, PLLC, Houston
Simcare Medical Research, LLC, Sugar Land
Sun Research Institute, San Antonio
Amarillo Med Spec LLP, Amarillo
American Clinical Trials, Buena Park
Valley Clinical Trials, Inc., Northridge
Scripps Whittier Diabetes Inst, La Jolla
Desert Oasis Hlthcr Med Group, Palm Springs
Valley Research, Fresno
Diablo Clinical Research, Inc., Walnut Creek
Clinical Trials Research_Sacramento, Lincoln
Capital Clin Res Ctr,LLC, Olympia
Ileana J Tandron APMC, Slidell
MassResearch, LLC, Waltham
Milek, Hohenmölsen, Hohenmölsen
Hayashi Diabetes Clinic, Chigasaki-shi
Heiwadai Hospital, Miyazaki
Tokuyama clinic, Chiba
Futata Tetsuhiro Clinic Meinohama, Fukuoka-shi, Fukuoka
Naka Kinen Clinic, Ibaraki
Yuri Ono Clinic, Sapporo-shi, Hokkaido
Oyama East Clinic, Tochigi
Juntendo University Hospital_Tokyo, Tokyo
Noritake Clinic, Ushiku-shi, Ibaraki
Centrum Terapii Współczesnej J.M. Jasnorzewska S.K.A., Lodz
"NZOZ DiabMed Poradnia Diabetologiczna", Poznan
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych I Administracji, Warsaw
Unidade Local de Saúde de Matosinhos, Senhora Da Hora, Matosinhos
Hospital Garcia de Orta, Almada
Centro Hospitalar Lisboa Ocidental, Lisbon
Unidade Local de Saúde de Santo António, E.P.E, Porto
Centro Hospitalar de São João, Porto
Hospital da Luz Arrabida, Vila Nova de Gaia
Korea University Anam Hospital, Seoul
Seoul National University Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Nowon Eulji Medical Center, Eulji University, Seoul
"Department of Medical Service and Rehabilitation of Artem", Kyiv
Institute of Endocrinology and Metabolism of AMSU, Kyiv
Lead Sponsor
Novo Nordisk A/S
INDUSTRY